PDF Número - Nefrología

G.M. London. Arterial calcification
revisiones cortas
subclinical epicardial coronary calcification in men and women the
Framingham Heart Study. Circulation 2002;106:1189-91.
21. Koh JM, Khang YH, Jung CH. Higher circulating hsCRP levels are
associated with lower bone mineral density in healthy pre- and
postmenopausal women: evidence for a link between systemic
inflammation and osteoporosis. Osteoporos Int 2005;16:1263-71.
22. Aikawa E, Nahrendorf M, Figuiredo JL. Osteogenesis associates
with inflammation in early-stage atherosclerosis evaluated by
molecular imaging in vivo. Circulation 2007;116:2841-50.
23. Tintut Y, Patel J, Territo M. Monocyte macrophage regulation of
vascular calcification in vitro. Circulation 2002;105:650-5.
24. Moe SM, Duan D, Doehle BP. Uremia induces the osteoblast
differentiation factor Cbfa1 in human blood vessels. Kidney Int
2003;63:1003-11.
25. Lomashvili K, Cobbs S, Hennigar RA. Phosphate-induced vascular
calcification: role of pyrophosphate and osteopontin. J Am Soc
Nephrol 2004;15:1392-401.
26. Zhao MM, Xu MJ, Cai Y. Mitochondrial reactive oxygen species
promote p85 nuclear translocation mediating high phosphateinduced
vascular calcification in vitro and in vivo. Kidney Int
2011;79:1071-9.
27. Schafer C, Heiss A, Schwarz A. The serum protein alpha 2-
Heremans-Schmid glycoprotein/fetuin-A is a systemically acting
inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
28. Luo G, Ducy P, McKee MD. Spontaneous calcification of arteries and
cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
29. Sweatt A, Sane DC, Hutson SM, Wallin R. Matrix Gla protein (MGP)
and bone morphogenetic protein-2 in aortic calcified lesions of
aging rats. J Thromb Haemost 2003;1:178-85.
30. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular
smooth muscle cells: inhibition by osteopontin. Circ Res
1999;84:166-78.
31. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin
inhibits artery calcification induced by warfarin and by vitamin D.
Arterioscler Thromb Vasc Biol 2001;21:1610-6.
32. Lin TC, Tintut Y, Lyman A, Demer LL, Hsiai TK. Mechanical response
of a calcified plaque model to fluid shear force. Ann Biomed Engl
2006;34:1535-41.
33. Hoshino T, Chow LA, Hsu JJ. Mechanical stress analysis of rigid
inclusion in distensible material: a model of atherosclerotic
calcification and plaque vulnerability. Am J Physiol Heart Circ
Physiol 2009;297:H802-H810.
34. Guérin AP, London GM, Marchais SJ, Métivier F. Arterial stiffness
and vascular calcifications in end-stage renal disease. Nephrol Dial
Transplant 2000;15:1014-21.
35. O’Rourke MF. Mechanical principles in arterial disease.
Hypertension 1995;26:2-9.
36. Brandenburg VM, Floege J. Adynamic bone disease-bone and
beyond. NDT Plus 2008;3:135-47.
37. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the
progression of coronary and aortic calcification in hemodialysis
patient. Kidney Int 2002;62:245-52.
38. Suki WN, Zabaneh R, Cangiano JL. Effects of sevelamer and
calcium-based phosphate binders on mortality in hemodialysis
patients. Kidney Int 2007;72:1130-7.
39. Bolland MJ, Barber PA, Doughty RN. Vascular events in healthy
older women receiving calcium supplementation: randomised
controlled trial. BMJ 2008;336:262-6.
Enviado a Revisar:28 Jun. 2011 | Aceptado el: 27 Ago. 2011
Nefrologia 2011;31(6):644-7
647